Document Type : Editorial
1.Gametogenesis Research Center, Kashan University of Medical Sciences, Kashan, Iran.
Editorial: Exosomes, extracellular vesicles secreted from cells, are carriers containing proteins, lipids, and nucleic acids. By adhering and releasing their contents to the recipient cells, exosomes play a major role in cellular communication. Based on a variety of their originated cells, cargos, and physiologic state of releasing cells, Exosomes have been attributed to an extended range of roles such as signal transduction, reprogramming, epigenetic modification, and inflammation (1). Recently, it has been shown that exosomes are also involved in pathological mechanisms of diseases, such as neurodegenerative diseases, tumors, chronic inflammation, and cardiovascular diseases (2). Moreover, exosomes have been used as diagnostic markers for different diseases since their cargos and contents can reflect the physiological or pathological processes of the cells of origin. Because of having features of being the carrier, they can be considered a vehicle for drug delivery or gene therapy (3). Due to the reasons above cited, researchers have been focused on the isolation, characterization, and therapeutic application of exosomes from various cells using in vitro cell culture (4). Fetal bovine serum (FBS) because of having a lot of growth factors is widely used for in vitro cell culture but it also has a high content of exosomes which interfere with the characterization and isolation procedures of the cultivated cells. Thus, for eliminating exosomes of FBS, several protocols have been routinely applied using ultrafiltration, sonication, precipitation, and ultracentrifuge procedures most of which are time-consuming and complex (5). Here, we suggest that knockout serum replacement (KSR) can be used instead of exosome-depleted FBS. KSR is a substitute for FBS in the culture of embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) and also for when animal proteins might create an immunologic reaction in cases where the cells need to be injected for clinical application (6).
KSR is an exosome-free serum since it has a defined formulation and stable concentration of ingredients. In summary, using an exosome-free serum is the first step in the isolation and purification of exosomes from in vitro cell cultures and KSR can be a more beneficial and efficient option than exosome-depleted FBS.
Special thanks to the Kashan University of Medical Sciences.
Conflict of interest
There is not any kind of conflict of interest.
There is no funding.
ESCs Embryonic stem cells
FBS Fetal bovine serum
iPSCs Induced pluripotent stem cells
KSR knockout serum replacement